Predicting Response to Treatment in Systemic Sclerosis-Related Interstitial Lung Disease in a Multicenter Observational Cohort and CONQUER
|Scleroderma Research Foundation
|Male and Female Patients
|Elana Bernstein, MD: 212-305-4308 / email@example.com
The purpose of this study is to develop a cohort of patients with early scleroderma and to collect data on clinical outcomes, radiological tests, laboratory tests, and to obtain biological specimens for testing.
Elana Bernstein, MD
|Are you at least 18 years old?
|Have you been diagnosed with systemic sclerosis (scleroderma)?